| 3501 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
62 |
| 3502 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
31 |
| 3503 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
4 |
| 3504 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
15 |
| 3505 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
64 |
| 3506 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy |
Metabolic |
2021 |
Standard Therapy |
Poland |
8 |
| 3507 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
32 |
| 3508 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
19 |
| 3509 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
49 |
| 3510 |
Bone Marrow |
Allogeneic |
Aplastic Anemia; Paroxysmal Nocturnal Hemoglobinuria |
Hematology |
2021 |
Standard Therapy |
Poland |
32 |
| 3511 |
Bone Marrow |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
16 |
| 3512 |
Bone Marrow |
Allogeneic |
Bcr-Abl Pos. All |
Hematology |
2021 |
Standard Therapy |
Poland |
51 |
| 3513 |
Bone Marrow |
Allogeneic |
Beta Thalassemia Major |
Hematology |
2021 |
Standard Therapy |
Poland |
14 |
| 3514 |
Bone Marrow |
Allogeneic |
Cartilage Hair Hypoplasia |
Orthopedics |
2021 |
Standard Therapy |
Poland |
7 |
| 3515 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2021 |
Standard Therapy |
Poland |
2 |
| 3516 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2021 |
Standard Therapy |
Poland |
1 |
| 3517 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2021 |
Standard Therapy |
Poland |
2 |
| 3518 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
44 |
| 3519 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
64 |
| 3520 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
47 |
| 3521 |
Bone Marrow |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
53 |
| 3522 |
Bone Marrow |
Allogeneic |
Combined Immunodeficiency |
Hematology |
2021 |
Standard Therapy |
Poland |
1 |
| 3523 |
Bone Marrow |
Allogeneic |
Combined Immunodeficiency Syndrome With Hyper-Igm |
Hematology |
2021 |
Standard Therapy |
Poland |
5 |
| 3524 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
4 |
| 3525 |
Bone Marrow |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2021 |
Standard Therapy |
Poland |
3 |
| 3526 |
Bone Marrow |
Allogeneic |
Hurler Syndrome |
Hematology |
2021 |
Standard Therapy |
Poland |
3 |
| 3527 |
Bone Marrow |
Allogeneic |
Immunodeficiency |
Hematology |
2021 |
Standard Therapy |
Poland |
2 |
| 3528 |
Bone Marrow |
Allogeneic |
Inherited Immune System Disorder |
Hematology |
2021 |
Standard Therapy |
Poland |
1 |
| 3529 |
Bone Marrow |
Allogeneic |
Ipex- Other Immune |
Hematology |
2021 |
Standard Therapy |
Poland |
20 |
| 3530 |
Bone Marrow |
Allogeneic |
Leukemia Lymphoblastic Acuta |
Hematology |
2021 |
Standard Therapy |
Poland |
6 |
| 3531 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2021 |
Standard Therapy |
Poland |
70 |
| 3532 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2021 |
Standard Therapy |
Poland |
10 |
| 3533 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2021 |
Standard Therapy |
Poland |
2 |
| 3534 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2021 |
Standard Therapy |
Poland |
30 |
| 3535 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2021 |
Standard Therapy |
Poland |
67 |
| 3536 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2021 |
Standard Therapy |
Poland |
59 |
| 3537 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2021 |
Standard Therapy |
Poland |
59 |
| 3538 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2021 |
Standard Therapy |
Poland |
69 |
| 3539 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2021 |
Standard Therapy |
Poland |
55 |
| 3540 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2021 |
Standard Therapy |
Poland |
14 |
| 3541 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2021 |
Standard Therapy |
Poland |
41 |
| 3542 |
Bone Marrow |
Allogeneic |
Osteopetrosis |
Hematology |
2021 |
Standard Therapy |
Poland |
7 |
| 3543 |
Bone Marrow |
Allogeneic |
Other Leukemia Specify |
Hematology |
2021 |
Standard Therapy |
Poland |
35 |
| 3544 |
Bone Marrow |
Allogeneic |
Other Myelofibrosis |
Hematology |
2021 |
Standard Therapy |
Poland |
72 |
| 3545 |
Bone Marrow |
Allogeneic |
Refractory Cytopenia |
Hematology |
2021 |
Standard Therapy |
Poland |
7 |
| 3546 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
23 |
| 3547 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
53 |
| 3548 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
12 |
| 3549 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
5 |
| 3550 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
13 |
| 3551 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
12 |
| 3552 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
32 |
| 3553 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2021 |
Standard Therapy |
Poland |
1 |
| 3554 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2021 |
Standard Therapy |
Poland |
1 |
| 3555 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2021 |
Standard Therapy |
Poland |
9 months |
| 3556 |
Apheresis |
Allogeneic |
Acute Biphenotypic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
28 |
| 3557 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
17 |
| 3558 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
73 |
| 3559 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
38 |
| 3560 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
31 |
| 3561 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
24 |
| 3562 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
27 |
| 3563 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
54 |
| 3564 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
51 |
| 3565 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
65 |
| 3566 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
47 |
| 3567 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
10 |
| 3568 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
23 |
| 3569 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
5 |
| 3570 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
28 |
| 3571 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3572 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
13 |
| 3573 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
55 |
| 3574 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
42 |
| 3575 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
20 |
| 3576 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3577 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
52 |
| 3578 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
68 |
| 3579 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
32 |
| 3580 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
19 |
| 3581 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
61 |
| 3582 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
42 |
| 3583 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
3 |
| 3584 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
29 |
| 3585 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
8 |
| 3586 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
54 |
| 3587 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
20 |
| 3588 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
6 |
| 3589 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
61 |
| 3590 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
24 |
| 3591 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
66 |
| 3592 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
38 |
| 3593 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia – Relapse |
Hematology |
2021 |
Standard Therapy |
Poland |
38 |
| 3594 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
40 |
| 3595 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3596 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
23 |
| 3597 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
59 |
| 3598 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
62 |
| 3599 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
73 |
| 3600 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
41 |